X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (54) 54
index medicus (38) 38
female (31) 31
cell line, tumor (26) 26
animals (25) 25
oncology (23) 23
cancer (21) 21
mice (20) 20
male (18) 18
genetic aspects (16) 16
genotype (16) 16
middle aged (16) 16
polymorphism, genetic (16) 16
apoptosis (14) 14
cell proliferation - drug effects (14) 14
risk factors (14) 14
polymorphism (13) 13
urology & nephrology (13) 13
xenograft model antitumor assays (13) 13
adult (12) 12
angiogenesis (12) 12
article (12) 12
case-control studies (12) 12
research (12) 12
gene frequency (11) 11
india (11) 11
polymerase chain reaction (10) 10
antineoplastic agents - pharmacology (9) 9
cytokines (9) 9
expression (9) 9
genetic predisposition to disease (9) 9
breast neoplasms - drug therapy (8) 8
care and treatment (8) 8
cells (8) 8
chemistry, medicinal (8) 8
disease (8) 8
tumors (8) 8
aged (7) 7
apoptosis - drug effects (7) 7
association (7) 7
biochemistry & molecular biology (7) 7
breast cancer (7) 7
cell biology (7) 7
drug therapy (7) 7
health aspects (7) 7
research article (7) 7
risk (7) 7
signal transduction (7) 7
alleles (6) 6
bladder cancer (6) 6
child (6) 6
development and progression (6) 6
genes (6) 6
receptors, calcitriol - genetics (6) 6
signal transduction - drug effects (6) 6
activation (5) 5
adolescent (5) 5
anticancer properties (5) 5
cell movement - drug effects (5) 5
chemistry, organic (5) 5
diabetes (5) 5
gene expression regulation, neoplastic - drug effects (5) 5
human umbilical vein endothelial cells (5) 5
il-1-beta (5) 5
medicine (5) 5
metastasis (5) 5
ovarian cancer (5) 5
pcr-rflp (5) 5
proteins (5) 5
sarcomas (5) 5
science (5) 5
single nucleotide polymorphism (5) 5
stat3 (5) 5
studies (5) 5
susceptibility (5) 5
type 2 diabetes (5) 5
analysis (4) 4
angiogenesis inhibitors - pharmacology (4) 4
antineoplastic agents - chemical synthesis (4) 4
biochemistry (4) 4
breast neoplasms - pathology (4) 4
cancer treatment (4) 4
cancer-cells (4) 4
carcinoma (4) 4
chemotherapy (4) 4
diabetes mellitus, type 2 - genetics (4) 4
disease models, animal (4) 4
estrogen (4) 4
gene expression (4) 4
genetic research (4) 4
growth (4) 4
ho-3867 (4) 4
il-1ra (4) 4
inhibition (4) 4
inhibitors (4) 4
interleukins (4) 4
mice, scid (4) 4
multidisciplinary sciences (4) 4
neovascularization, pathologic - drug therapy (4) 4
neovascularization, pathologic - metabolism (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 08/2012, Volume 7, Issue 8, p. e39444
The angiogenic process is controlled by variety of factors of which the vascular endothelial growth factor (VEGF) pathway plays a major role. A series of... 
TRANSFORMATION | DOMAIN | METASTASIS | MULTIDISCIPLINARY SCIENCES | AGENTS | INHIBITORS | HEPARIN | TUMOR-GROWTH | Endothelium, Vascular - cytology | Cell Proliferation | Endothelium, Vascular - drug effects | Vascular Endothelial Growth Factor A - metabolism | Antineoplastic Agents - metabolism | Cell Movement - drug effects | Molecular Mimicry | Animals | Hydrogen Bonding | Small Molecule Libraries | Cell Line, Tumor | Protein Binding | Antineoplastic Agents - pharmacology | Mice | Molecular Docking Simulation | Drug Screening Assays, Antitumor | Anticoagulants (Medicine) | Metastasis | Comparative analysis | Sulfates | Hydrogen | Vascular endothelial growth factor | Cell proliferation | Molecular structure | Liver | Amino acids | Kinases | Cancer therapies | Hydrogen bonding | Molecular docking | Anticancer properties | Metastases | Proteins | Angiogenesis | Biomedical materials | Antitumor agents | Epidermal growth factor | Osteosarcoma | Imidazole | Cell cycle | Bonding strength | Chemical bonds | Tumor necrosis factor-TNF | Biocompatibility | Life sciences | Inhibition | Chemical synthesis | Bonding | Binding | Heparan sulfate | Cytokines | Cell division | Endothelial cells | Children & youth | Vascular endothelial growth factor receptors | Bone cancer | Chemistry | Predictions | Surface plasmon resonance | Chondroitin sulfate | Heparin | Sulfate | Binding sites | Cell migration | Tumors
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2015, Volume 10, Issue 7, pp. e0133302 - e0133302
Journal Article
International Journal of Cancer, ISSN 0020-7136, 11/2017, Volume 141, Issue 9, pp. 1856 - 1866
Advanced ovarian clear cell carcinoma (OCCC) carries a very poor prognosis in large part secondary to the extremely high rate of resistance to standard... 
ovarian clear cell carcinoma | curcumin analog | HO‐3867 | angiogenesis | STAT3 | HO-3867 | CANCER-CELLS | ANTICANCER EFFICACY | ACTIVATOR | ONCOLOGY | THERAPEUTIC TARGET | PERSPECTIVES | TRANSCRIPTION-3 | DEGRADATION | EXPRESSION | SIGNAL TRANSDUCER | Apoptosis - drug effects | Humans | Ovarian Neoplasms - pathology | Ovarian Neoplasms - genetics | Piperidones - administration & dosage | Xenograft Model Antitumor Assays | Cell Movement - drug effects | Drug Resistance, Neoplasm - genetics | Animals | Signal Transduction - drug effects | Cell Line, Tumor | Female | Adenocarcinoma, Clear Cell - pathology | Cell Proliferation - drug effects | Mice | Gene Expression Regulation, Neoplastic - drug effects | Adenocarcinoma, Clear Cell - genetics | Ovarian Neoplasms - drug therapy | STAT3 Transcription Factor - genetics | Adenocarcinoma, Clear Cell - drug therapy | Development and progression | Chemotherapy | Carcinoma | Cancer | Apoptosis | Cell proliferation | Biotechnology | Bcl-2 protein | Transcription | Leukocyte migration | Activation | Taxane | Caspase-3 | Anticancer properties | Ovarian cancer | Platinum | Inhibition | Cell survival | Stat3 protein | Caspase | Poly(ADP-ribose) polymerase | Patients | Endothelial cells | Caspase-7 | Medical prognosis | In vitro methods and tests | Umbilical vein | Cell migration | Index Medicus | Ovarian clear cell carcinoma
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2012, Volume 7, Issue 4, p. e35513
Background: Recent data indicate the Signal Transducer and Activator of Transcription 3 (STAT3) pathway is required for VEGF production and angiogenesis in... 
BREAST-CANCER CELLS | ACTIVATOR | ENDOTHELIAL-CELLS | BIOLOGY | TRANSCRIPTION-3 | OSTEOSARCOMA | EXPRESSION | TUMORS | GROWTH-SUPPRESSIVE ACTIVITY | PRECLINICAL TESTING PROGRAM | SIGNAL TRANSDUCER | Osteosarcoma - drug therapy | Neovascularization, Physiologic - drug effects | Humans | Actins - metabolism | Anthraquinones - administration & dosage | Angiogenesis Inhibitors - administration & dosage | Microtubules - metabolism | Female | Phosphorylation - drug effects | Myocytes, Smooth Muscle - drug effects | Vascular Endothelial Growth Factor A - pharmacology | Osteosarcoma - metabolism | Cell Survival - drug effects | Angiogenesis Inhibitors - pharmacology | Mice, SCID | Sulfonamides - pharmacology | Xenograft Model Antitumor Assays | Cell Movement - drug effects | Animals | Neovascularization, Pathologic - drug therapy | Cell Line, Tumor | Anthraquinones - pharmacology | Cell Proliferation - drug effects | Mice | Neovascularization, Pathologic - metabolism | STAT3 Transcription Factor - antagonists & inhibitors | Sulfonamides - administration & dosage | Endothelial Cells - drug effects | Antimitotic agents | Antineoplastic agents | Vascular endothelial growth factor | Analysis | Pediatrics | Phosphorylation | Transcription | Tissue factor | Staining | Smooth muscle | Metastasis | Kinases | Cell adhesion & migration | Anticancer properties | Angiogenesis | Liver cancer | Biomedical materials | Cell growth | Tubulin | Osteosarcoma | Actin | Xenografts | Biocompatibility | Physiology | Inhibition | Growth factors | Plugs | CD34 antigen | Medical research | Wound healing | Fibroblast growth factor 1 | Stat3 protein | Pharmacology | Breast cancer | Endothelial cells | Gelatinase B | Children & youth | Robust control | Bone cancer | Inhibitors | Antiangiogenics | Antitumor activity | Umbilical cord | Molecular biology | Tumors | Apoptosis
Journal Article
Hepatology, ISSN 0270-9139, 02/2014, Volume 59, Issue 2, pp. 555 - 566
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2017, Volume 12, Issue 7, p. e0180297
Journal Article
PLoS ONE, ISSN 1932-6203, 10/2012, Volume 7, Issue 10
Figures 1-8 were placed in the wrong locations. Citation: Basappa, Sugahara K, Thimmaiah KN, Bid HK, Houghton PJ, Rangappa KS (2012) Correction: Anti-Tumor... 
Vascular endothelial growth factor | Antitumor agents | Anticancer properties
Journal Article
Oncogene, ISSN 0950-9232, 01/2017, Volume 36, Issue 2, pp. 168 - 181
Journal Article